Use of N-methylene phosphonic chitosan to obtain an isoniazid prodrug

Revista Brasileira de Ciencias Farmaceuticas/Brazilian Journal of Pharmaceutical Sciences

Volumn 40, Issue 3, 2004, Pages 335-344

  Rando, Daniela Gonçales ^a   Brandt, Carlos Alberto ^b   Ferreira, Elizabeth Igne ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b INSTITUTO BUTANTAN   (Brazil)

Author keywords

Chitosan; Isoniazid; N methylene phosphonic chitosan; Prodrug

Indexed keywords

1 (PYRIDINE 4 CARBONYL)TETRAHYDROPYRIDAZINE 3,6 DIONE; CHITOSAN DERIVATIVE; DRUG CARRIER; ISONIAZID; N METHYLENE PHOSPHONIC CHITOSAN; PRODRUG; PYRIDAZINE DERIVATIVE; SUCCINYLISONIAZID; UNCLASSIFIED DRUG;

ARTICLE; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG FORMULATION; DRUG SOLUBILITY; DRUG SYNTHESIS; HOST CELL; HYDROPHILICITY; MACROPHAGE; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS; TUBERCULOSIS CONTROL;

EID: 11144267731     PISSN: 15169332     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. BLOOM, B.R.; ROOK G. A. W. Mechanisms of pathogenesis in tuberculosis. In: BLOOM, B. R., Ed. Tuberculosis: pathogenesis, protection and control, Washington: ASM Press, 1994. p.3-11.
2. BUNDGAARD, H., Ed. Design of prodrugs. Amsterdam: Elsevier, 1985.
3. BUNDGAARD, H., Novel chemical approaches in prodrug design. Drugs Fut., Barcelona, v.16, n. 5, p. 443-453, 1991.
4. CHUNG, M.C.; FERREIRA, E.I., O processo de latenciação no planejamento de fármacos. Quím. Nova, São Paulo, v.22, n.1, p.75-84, 1999.
5. DORIGUETTO, A. C.; SILVA, C.H.T.D.; RANDO, D. G.; FERREIRA, E. I.; ELLENA, J. A. 4-(2-Isonicotinoylhydrazino)-4-oxobutanoic acid. Acta Crystallogr. E, v.59, p.288-289, 2003.
6. ETTMAYER, P.; AMIDON, G. L.; CLEMENT, B.; TESTA, B. Lessons learned from marketed and investigational prodrugs. J. Med. Chem., Washington, v. 47, p.2393-2404, 2004.
7. FÄTKENHEUER, G.; TAELMAN, H.; LEPAGE, P.; SCHWENK, A.; WENZEL, R. The return of tuberculosis. Diagn. Microbiol. Infect Dis., Amsterdam, v. 34, p. 139-146, 1999.
8. HERAS, A.; RODRÍGUEZ, N.M.; RAMOS, V.M.; AGULLÓ, E. N-methylene phosphonic chitosan: a novel soluble derivative. Carbohydr. Polym., Amsterdam, v. 44, p. 1-8, 2001.
9. HIRANO, S.; SEINO, H.; AKIYAMA, Y.; NONAKA, I. Chitosan: A biocompatible material for oral and intravenous administrations. Progress in Biomedical Polymers. New York: Plenum Press, 1991. p. 283-290.
10. ISEMAN, M. Management of multidrug-resistant tuberculosis. Chemotherapy, Basel, v.45, suppl. 2, p. 3-11, 1999.
11. KUBOTA, N.; TATSUMOTO N.; SANO T.; TOYA K. A simple preparation of half N-acetylated chitosan highly soluble in water and aqueous organic solvents. Carbohydr. Res., Amsterdam, v.324, p.268-274, 2000.
12. KROGSGAARD-LARSEN, P.; LILJEFORS, T.; MADSEN, U. Eds., A textbook of drug design and development. 2. ed. Harwood: Academic Publishers, 1996. 543 p.
13. MUZZARELLI, R. A. A.; MUZZARELLI, C. Eds. Chitosan in pharmacy and chemistry. Grottammari: Atec, 2002. 524 p.
14. NISHIMURA, S.; KAI H.; SHINADA, K.; YOSHIDA, T.; TOKURA, S.; KURITA, K.; NAKASHIMA, H.; YAMAMOTO, N.; URYU, T. Regioselective syntheses of sulfated polysaccharides: specific anti-HIV-1 activity of novel chitin sulfates. Carbohydr. Res., Amsterdan. v. 306, p. 427-433, 1998.
15. RATTAN, A.; KALIA, A.; AHMAD, N. Multidrug-resistant Mycobacterium tuberculosis: molecular perspectives. Emerg. Inf. Dis., Atlanta, v.4, p.195-208, 1998.
16. SATO, M.; ONISHI, H.; KITANO, M.; YOSHIHARU, M.; NAGAI, T. Preparation and drug release characteristics of the conjugates of mitomycin C with glycol-chitosan and N-succinyl-chitosan. Biol. Pharm. Bull., Toquio, v.19, n.2, p. 241-245, 1996.
17. SCHACHT, E.H.; VANSTEENKISTE, S.; SEYMOUR, L. Macromolecular carriers for drug targeting. In: WERMUTH, C.G., Ed. The practice of medicinal chemistry. London: Academic Press, 1996. p. 717-738.
18. SHIBATA, Y.; METZGER, W. J.; MYRVIK, Q. N. Chitin particle-induced cell-mediated immunity is inhibited by soluble mannan: mannose receptor-mediated phagocytosis initiates IL-12 production. J. Immunol., Baltimore, v.159, p.2462-2467, 1997.
19. SHIGEMASA, Y.; USUI, H.,; MORIMOTO, M.; SAIMOTO, H.; OKAMOTO, Y.; MINAMI, S.; SASHIWA, H. Chemical modification of chitin and chitosan: preparation of partially deacetylated chitin derivatives via a ring-opening reaction with cyclic acid anhydrides in lithium chloride/N,N-dimethylacetamide. Carbohydr. Polym., Amsterdam, v.39, p.237-243, 1999.
20. TAYLOR, J. B.; KENNEWELL, P.D. Modern medicinal chemistry. Chichester: Ellis Horwood, 1993. 290 p.
21. WERMUTH, C.G. Designing prodrugs and bioprecursors. In: ed. The practice of medicinal chemistry. London: Academic Press, 2003. p. 561-586.
22. WORLD HEALTH ORGANIZATION. Global tuberculosis control. Tuberculosis handbook. Genebra, 1998.
23. WORLD HEALTH ORGANIZATION. Global tuberculosis control. WHO report 2000, Genebra, 2000.
24. ZANG, Y.; BROSER, M.; COHEN, H.; BODKIN, M.; LAW, K.; REIBMAN, J.; ROM, W.N. Enhanced interleukin-8 release and gene expression in macrophages after exposure to Mycobacterium tuberculosis and its components. J. Clin. Invest., New Haven, v.95, p. 586-592, 1995.
25. ZONG, Z.; KIMURA, Y.; TAKAHASHI, M.; YAMANE, H. Characterization of chemical and solid state structures of acylated chitosans. Polymer, Amsterdam, v. 41, p.899-906, 2000.